Verus Evidence Standards



Our Approach to Scientific Evidence

At Verus PhytoMed™, botanical compounds are evaluated using a structured, evidence-informed framework grounded in human clinical research.

Scientific research varies widely in quality, design, and applicability. For this reason, individual studies are not viewed in isolation. Instead, evidence is assessed based on the totality of available research, with attention to consistency, study design, and clinical relevance. The goal is to present a balanced and transparent interpretation of what current research suggests.

Hierarchy of Evidence

This hierarchy is used to guide interpretation rather than serve as a rigid grading system. Not all types of research carry the same weight.

When reviewing botanicals, priority is generally given to the following:

1. Systematic Reviews and Meta-Analyses

  • Combine data from multiple randomized controlled trials

  • Provide the most comprehensive assessment of available evidence

  • Allow evaluation of consistency across studies

2. Randomized Controlled Trials (RCTs)

  • Evaluate effects in human populations under controlled conditions

  • Help evaluate associations between an intervention and specific outcomes

  • Considered a strong form of clinical evidence

3. Observational and Cohort Studies

  • Examine patterns and associations in real-world populations

  • May provide supportive evidence but are more limited in establishing causality

4. Mechanistic and Preclinical Research

  • Includes laboratory and animal studies

  • Helps explain biological pathways and plausibility

  • Does not directly translate to clinical outcomes in humans

This hierarchy guides how findings are interpreted and presented.

Key Factors in Evidence Evaluation

1. Study Design and Quality

We consider:

  • Randomization and control groups

  • Sample size

  • Study duration

  • Risk of bias

Higher-quality study designs are given greater weight.

2. Population Studied

Research findings may depend on:

  • Age

  • Baseline health status

  • Presence of metabolic conditions

  • Concurrent therapies

Results from specific populations may not apply universally.

3. Outcome Measures

Many botanical studies focus on biomarkers, such as:

  • Fasting glucose

  • HbA1c

  • Lipid levels

  • Inflammatory markers

While these markers are clinically relevant, they are not the same as long-term clinical outcomes.

This distinction is considered when interpreting findings.

4. Consistency Across Studies

Greater confidence is placed on findings that are:

  • Observed across multiple independent studies

  • Reproduced in different populations

  • Supported by meta-analyses

Isolated findings are interpreted more cautiously.

5. Magnitude and Clinical Relevance

In addition to statistical significance, we consider:

  • The size of the observed effect

  • Whether changes are clinically meaningful

  • Whether findings are consistent across endpoints

  • Whether effects are sustained over time (when data is available)

6. Duration of Evidence

Many studies in botanical research:

  • Last between 8–12 weeks

  • Focus on short-term biomarker changes

Long-term outcomes are often not available, and this limitation is acknowledged.

How Findings Are Presented

To reflect the nature of scientific research, findings are described using neutral, non-definitive language such as:

  • “studied”

  • “associated with”

  • “reported”

  • “suggests”

This approach is intended to avoid overstating conclusions.

Evidence Strength (Framework)

While formal grading systems vary, evidence is generally interpreted within the following framework:

  • Stronger Evidence
    Multiple randomized trials and meta-analyses showing consistent findings

  • Moderate Evidence
    Several clinical studies with generally consistent results, but some variability

  • Emerging Evidence
    Limited human data or reliance on smaller or shorter-duration studies

  • Preclinical Evidence
    Primarily laboratory or animal research without direct human confirmation

These categories are descriptive and are not intended as formal or standardized grading systems.

Limitations of Botanical Research

When reviewing the literature, several common limitations are considered:

  • Variability in formulations and dosing

  • Differences in study populations

  • Short study durations

  • Reliance on surrogate biomarkers

  • Heterogeneity across trials

These factors may influence how results are interpreted.

Contextual Interpretation

Scientific findings are presented within context, not as definitive conclusions. Findings are not presented as recommendations for use.

The goal is to:

  • Provide clarity around what has been studied

  • Acknowledge uncertainty where it exists

  • Support informed interpretation of available evidence

Our Goal

Verus PhytoMed™ aims to provide:

  • Structured evaluation of botanical research

  • Transparent interpretation of scientific findings

  • Clear distinction between evidence types

  • Practical context for understanding study results

This framework is intended to support a more informed approach to evaluating botanical supplements.

Educational Notice
The information provided on this page is for educational purposes only and is not intended as medical advice, diagnosis, or treatment. Readers should consult qualified healthcare professionals for personal health decisions.

See how these evidence standards are applied in practice in the Botanical Library.